National Health (Listed Drugs on F1 or F2) Amendment Determination 2024 (No. 3)
I, Nikolai Tsyganov, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health and Aged Care, delegate of the Minister for Health and Aged Care, make the following determination.
Dated 29 April 2024
NIKOLAI TSYGANOV
Assistant Secretary
Pricing and PBS Policy Branch
Technology Assessment and Access Division
Department of Health and Aged Care
Contents
2 Commencement
3 Authority
4 Schedules
Schedule 1—Amendments
National Health (Listed Drugs on F1 or F2) Determination 2021 (PB 33 of 2021)
This instrument is the National Health (Listed Drugs on F1 or F2) Amendment Determination 2024 (No. 3).
This instrument may also be cited as PB 45 of 2024.
(1) Each provision of this instrument specified in column 1 of the table commences, or is taken to have commenced, in accordance with column 2 of the table. Any other statement in column 2 has effect according to its terms.
Commencement information | ||
Column 1 | Column 2 | Column 3 |
Provisions | Commencement | Date/Details |
1. The whole of this instrument | 1 May 2024. |
|
Note: This table relates only to the provisions of this instrument as originally made. It will not be amended to deal with any later amendments of this instrument.
(2) Any information in column 3 of the table is not part of this instrument. Information may be inserted in this column, or information in it may be edited, in any published version of this instrument.
This instrument is made under subsection 85AB(1) of the National Health Act 1953.
Each instrument that is specified in a Schedule to this instrument is amended or repealed as set out in the applicable items in the Schedule concerned, and any other item in a Schedule to this instrument has effect according to its terms.
National Health (Listed Drugs on F1 or F2) Determination 2021 (PB 33 of 2021)
1 Schedule 1, after item dealing with Amino acid formula with fat, carbohydrate without valine, leucine and isoleucine
omit:
Amino acid formula with vitamins and minerals, low phenylalanine and supplemented with docosahexaenoic acid and arachidonic acid
Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid
2 Schedule 1, after item dealing with Amino acid formula with vitamins and minerals without methionine
insert:
Amino acid formula with vitamins and minerals without methionine and supplemented with arachidonic acid and docosahexaenoic acid
3 Schedule 1, after item dealing with Amino acid formula with vitamins and minerals without valine, leucine and isoleucine
insert:
Amino acid formula with vitamins and minerals without valine, leucine and isoleucine with fat, carbohydrate and trace elements and supplemented with docosahexanoic acid
Amino acid formula with vitamins and minerals without valine, leucine, isoleucine and supplemented with arachidonic acid and docosahexaenoic acid
Amino acid formula with vitamins, minerals and long chain polyunsaturated fatty acids without phenylalanine
4 Schedule 1, after item dealing with Dexamfetamine
insert:
5 Schedule 1, after item dealing with Dornase alfa
insert:
Dostarlimab
6 Schedule 1, after item dealing with Magnesium
insert:
Mavacamten
7 Schedule 1, after item dealing with Probenecid
omit:
Procaine benzylpenicillin
8 Schedule 1, after item dealing with Sulthiame
insert:
Tafamidis